Immunotherapy resistance in esophageal cancer: Possible mechanisms and clinical implications

Esophageal cancer (EC) is a common malignant gastrointestinal (GI) cancer in adults. Although surgical technology combined with neoadjuvant chemoradiotherapy has advanced rapidly, patients with EC are often diagnosed at an advanced stage and the five-year survival rate remains unsatisfactory. The po...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Pinhao, Zhou, Jianfeng, Liang, Zhiwen, Yang, Yushang, Luan, Siyuan, Xiao, Xin, Li, Xiaokun, Zhang, Hanlu, Shang, Qixin, Zeng, Xiaoxi, Yuan, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478443/
https://www.ncbi.nlm.nih.gov/pubmed/36119033
http://dx.doi.org/10.3389/fimmu.2022.975986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478443/
https://www.ncbi.nlm.nih.gov/pubmed/36119033
http://dx.doi.org/10.3389/fimmu.2022.975986

Ejemplares similares